BRAIN Biotech AG Logo

BRAIN Biotech AG

Develops custom enzymes and microbes for the food, nutrition, and chemical industries.

BNN | F

Overview

Corporate Details

ISIN(s):
DE0005203947 (+1 more)
LEI:
391200JKPVHLD6JLZ107
Country:
Germany
Address:
Darmstädter Straße 34-36, 64673 Zwingenberg
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

BRAIN Biotech AG is a leading specialist in industrial biotechnology, providing research, development, and production of bio-based solutions. The company offers end-to-end contract research services, focusing on the discovery, engineering, and manufacturing of specialized enzymes, proteins, and microbial production strains. Leveraging an advanced technology portfolio, it develops customized biosolutions for industrial partners in sectors such as food, nutrition, and chemicals. Through collaborative R&D, BRAIN Biotech helps clients accelerate innovation, reduce project complexity, and create sustainable products and processes for the bioeconomy.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 09:05
Declaration of Voting Results & Voting Rights Announcements
English 5.7 KB
2025-09-03 09:30
Board/Management Information
BRAIN Biotech AG appoints Johan Jansen-Storbacka as Executive Vice President of…
English 14.1 KB
2025-08-28 07:30
Earnings Release
BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalys…
English 20.4 KB
2025-08-28 00:00
Quarterly Report
Q3 statement / Q3 financial report 2024/2025
English 274.7 KB
2025-08-25 07:30
Regulatory News Service
Corbion and BRAIN Biotech team to shape the future of innovation in nature-base…
English 11.5 KB
2025-07-23 08:30
Board/Management Information
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
English 13.4 KB
2025-06-23 08:05
Share Issue/Capital Change
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
English 22.4 KB
2025-05-28 07:30
Earnings Release
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
English 20.0 KB
2025-05-28 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
German 99.2 KB
2025-05-28 00:00
Interim Report
Half-yearly financial report 2024/2025
English 364.5 KB
2025-05-21 10:00
M&A Activity
BRAIN Biotech announces buy-out of minorities, new continental European product…
English 16.2 KB
2025-05-19 11:23
Report Publication Announcement
English 4.1 KB
2025-05-19 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
German 5.8 KB
2025-05-19 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
German 5.8 KB
2025-04-30 17:54
Earnings Release
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
English 6.0 KB

Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-03 Schneiders, Michael Board Buy None 25,000.00 EUR
2025-01-16 Moelker, Adriaan Board Buy None 35,795.96 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.